Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- RM 370 pro-SP-B intramolecular inter-molecular
- Product Overview:
Surfactant protein B (SP-B) is a hydrophobic surfactant protein and member of the saposin-like family encoded by SFTBP in humans.{54715} Mature SP-B is a 79-amino acid peptide formed by cleavage of proSP-B that contains three intramolecular disulfide bridges, which stabilize the tertiary structure. SP-B is expressed in alveolar type II cells, functions as a homodimer formed via intermolecular disulfide bond formation, and is required for the assembly of pulmonary surfactant, as well as the formation of stable surface-active films at the air-liquid alveolar interface. Blood levels of SB-P are increased in patients with mechanical ventilation- or pulmonary edema-induced acute alveolar cell damage.{54715,54716} Mutations in SFTBP induce SP-B deficiency, an autosomal recessive disorder in infants characterized by progressive hypoxemic respiratory failure in the first year of life.{54717} Cayman’s Surfactant Protein B Rabbit Monoclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.